Indivior Pharmaceuticals, Inc. (INDV)
Data as of , from SEC Form 4 filings.
See up to 3 months of INDV. The 7-day demo opens the 1M and 3M ranges and puts INDV on your watchlist.
Start 7-day demoLatest INDV insider trades
About Indivior Pharmaceuticals, Inc. (INDV)
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
- NORTH CHESTERFIELD, VA
- 838
- 2014
- XNAS
INDV Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 3,000 | $108K |
INDV insider transactions (Form 4)
5034 Form 4 filings on record, the earliest from Jan 28, 2026, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Woodrow D. Anderson - Officer | Open-market purchase | Common Stock | 1,500 | $35.69 | $54K | |
| Woodrow D. Anderson - Officer | Open-market purchase | Common Stock | 1,500 | $36.28 | $54K | |
| Christian Heidbreder - Officer | Open-market sale | Common Stock | 18,586 | $41.14 | $765K | |
| Joseph Ciaffoni - Officer | Option exercise | Performance Stock Units | 1,266,903 | - footnote F2 | - | |
| Joseph Ciaffoni - Officer | Option exercise | Common Stock | 1,266,903 footnote F1 | - footnote F2 | - | |
| Joseph Ciaffoni - Officer | Tax withholding / forfeiture | Common Stock | 612,549 footnote F3 | $38.32 | $23.47M | |
| ||||||
| Christian Heidbreder - Officer | Open-market sale | Common Stock | 18,586 | $38.06 | $707K | |
| Ryan Preblick - Officer | Open-market sale | Common Stock | 36,000 | $37.70 | $1.36M | |
| Tax withholding / forfeiture | Common Stock | 1,117 footnote F1 | $38.28 | $43K | ||
| Grant or award | Common Stock | 6,518 footnote F2 | $0.00 | - | ||
| ||||||
| Keith Humphreys - Director | Grant or award | Common Stock | 6,518 footnote F1 | $0.00 | - | |
| ||||||
| Stuart A. Kingsley - Director | Grant or award | Common Stock | 6,518 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 6,518 footnote F1 | $0.00 | - | ||
| ||||||
| Barbara Ryan - Director | Grant or award | Common Stock | 6,518 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 6,518 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Common Stock | 10,430 footnote F1 | $0.00 | - | ||
| ||||||
| Ryan Preblick - Officer | Option exercise | Common Stock | 6,302 | - footnote F1 | - | |
| Ryan Preblick - Officer | Tax withholding / forfeiture | Common Stock | 2,843 footnote F2 | $31.11 | $88K | |
| Ryan Preblick - Officer | Option exercise | Restricted Stock Units | 6,302 | - footnote F1 | - | |
| ||||||
| Barbara Ryan - Director | Open-market purchase | Common Stock | 8 | $31.09 | $249 | |
| Stuart A. Kingsley - Director | Open-market purchase | Common Stock | 940 | $31.87 | $30K | |
| Barbara Ryan - Director | Open-market purchase | Common Stock | 31 | $32.56 | $1K | |
| Woodrow D. Anderson - Officer | Option exercise | Common Stock | 5,946 | - footnote F2 | - | |
| Woodrow D. Anderson - Officer | Tax withholding / forfeiture | Common Stock | 2,682 footnote F4 | $31.98 | $86K | |
| Woodrow D. Anderson - Officer | Option exercise | Performance Stock Units | 23,975 | - footnote F2 | - | |
| Woodrow D. Anderson - Officer | Option exercise | Restricted Stock Units | 5,946 | - footnote F2 | - | |
| Woodrow D. Anderson - Officer | Option exercise | Common Stock | 18,364 footnote F1 | - footnote F2 | - | |
| Woodrow D. Anderson - Officer | Tax withholding / forfeiture | Common Stock | 8,283 footnote F3 | $31.98 | $265K | |
| ||||||
| Ryan Preblick - Officer | Option exercise | Performance Stock Units | 113,510 | - footnote F3 | - | |
| Ryan Preblick - Officer | Tax withholding / forfeiture | Common Stock | 87,597 footnote F1 | $31.98 | $2.80M | |
| Ryan Preblick - Officer | Option exercise | Common Stock | 86,949 footnote F2 | - footnote F3 | - | |
| ||||||
| Jeffrey W. Burris - Officer | Option exercise | Performance Stock Units | 104,300 | - footnote F2 | - | |
| Jeffrey W. Burris - Officer | Option exercise | Common Stock | 79,893 footnote F1 | - footnote F2 | - | |
| Jeffrey W. Burris - Officer | Tax withholding / forfeiture | Common Stock | 36,032 footnote F3 | $31.98 | $1.15M | |
| ||||||
| Christian Heidbreder - Officer | Option exercise | Performance Stock Units | 132,565 | - footnote F2 | - | |
| Christian Heidbreder - Officer | Option exercise | Common Stock | 101,544 footnote F1 | - footnote F2 | - | |
| Christian Heidbreder - Officer | Tax withholding / forfeiture | Common Stock | 45,797 footnote F3 | $31.98 | $1.46M | |
| ||||||
| Woodrow D. Anderson - Officer | Grant or award | Common Stock | 6,903 footnote F1 | $0.00 | - | |
| Woodrow D. Anderson - Officer | Grant or award | Performance Stock Units | 23,975 | $0.00 | - | |
| ||||||
| Ryan Preblick - Officer | Grant or award | Common Stock | 37,358 footnote F1 | $0.00 | - | |
| Ryan Preblick - Officer | Grant or award | Performance Stock Units | 113,510 | $0.00 | - | |
| ||||||
| Jeffrey W. Burris - Officer | Grant or award | Common Stock | 26,897 footnote F1 | $0.00 | - | |
| Jeffrey W. Burris - Officer | Grant or award | Performance Stock Units | 104,300 | $0.00 | - | |
| ||||||
| Christian Heidbreder - Officer | Grant or award | Common Stock | 33,622 footnote F1 | $0.00 | - | |
| Christian Heidbreder - Officer | Grant or award | Performance Stock Units | 132,565 | $0.00 | - | |
| ||||||
| Patrick A. Barry - Officer | Grant or award | Common Stock | 31,380 footnote F1 | $0.00 | - | |
| ||||||
| Joseph Ciaffoni - Officer | Grant or award | Common Stock | 79,976 footnote F1 | $0.00 | - | |
| ||||||
| Stuart A. Kingsley - Director | Grant or award | Common Stock | 3,722 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 5,955 footnote F1 | $0.00 | - | ||
| ||||||
| Barbara Ryan - Director | Grant or award | Common Stock | 3,722 footnote F1 | $0.00 | - | |
| ||||||
Recent INDV Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
INDV insider trading FAQ
What is the latest insider trade for INDV?
Indivior Pharmaceuticals, Inc. (INDV) had 2 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for INDV runs to 34 Form 4 filings, the earliest from 2026-01-28. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INDV stock?
2 insider purchases of INDV were filed in the last 90 days, totaling $108K.
How many insiders are selling INDV stock?
No insider sales of INDV were filed in the last 90 days. 3 sales are on record for this company.
Where can I see INDV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INDV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Woodrow D. Anderson view on EDGAR
- - Woodrow D. Anderson view on EDGAR
- - Christian Heidbreder view on EDGAR
- - Joseph Ciaffoni view on EDGAR
- - Christian Heidbreder view on EDGAR
- - Ryan Preblick view on EDGAR
- - Juliet Thompson view on EDGAR
- - Keith Humphreys view on EDGAR
- - Stuart A. Kingsley view on EDGAR
- - Daniel A. Ninivaggi view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where INDV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INDV with a 7-day demo
- INDV on your watchlist
- Every INDV Form 4 filing on record
- Up to 3 months of INDV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive